title: The therapeutic effects of EGCG on vitiligo.
abstract: Epigallocatechin-3-gallate (EGCG) is one of the main chemical constituents of green tea, which has been used as an important traditional Chinese medicine. Green tea has anti-inflammatory, anti-oxidant, and immunomodulatory properties. However, the effects of EGCG on vitiligo are not known. We assessed the role of EGCG in vitiligo induced by monobenzone in mice. We demonstrated that EGCG: delayed the time of depigmentation; reduced the prevalence of depigmentation; and decreased the area of depigmentation. Examination of depigmented skin treated with EGCG by reflectance confocal microscopy suggested increased numbers of epidermal melanocytes and histologic examination showed decreased perilesional accumulation of CD8(+) T cells. To further investigate the mechanism of the anti-inflammatory effects of EGCG, levels of inflammatory mediator tumor necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-6 were tested by enzyme-linked immunosorbent assay. Serum cytokine levels were significantly decreased after administration of EGCG compared with the model group. These results suggested that EGCG may have protective effects against vitiligo, and that it could contribute to suppression of activation of CD8(+) T cells and inflammatory mediators. Based on these results, 5% EGCG was considered to be the most suitable concentration for treating vitiligo, and was used for further study. In addition, we investigated the gene-expression profile of this model in relation to EGCG. Using a 4×44K whole genome oligo microarray assay, 1264 down-regulated genes and 1332 up-regulated genes were recorded in the 5% EGCG group compared with the model group, and selected genes were validated by real-time polymerase chain reaction. Our study demonstrated that EGCG administration was significantly associated with a decreased risk of vitiligo. EGCG could be a new preventive agent against vitiligo in the clinical setting.
authors.affiliation: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou 310009, PR. China.
authors.forename: Yiping
authors.initials: Y
authors.lastname: Zhu
authors.affiliation: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou 310009, PR. China.
authors.forename: Suiquan
authors.initials: S
authors.lastname: Wang
authors.affiliation: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou 310009, PR. China.
authors.forename: Fuquan
authors.initials: F
authors.lastname: Lin
authors.affiliation: Zhejiang University of Traditional Chinese Medicine, Hangzhou 310053, PR China.
authors.forename: Qing
authors.initials: Q
authors.lastname: Li
authors.affiliation: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou 310009, PR. China. Electronic address: xuaiehz@msn.com.
authors.forename: Aie
authors.initials: A
authors.lastname: Xu
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004195:Disease Models, Animal; D005260:Female; D006873:Hydroquinones; D007371:Interferon-gamma / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008544:Melanocytes / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal; D012880:Skin Pigmentation / Q000187:drug effects*; D059467:Transcriptome; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D014820:Vitiligo / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D006873:Hydroquinones; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D002392:Catechin; C006429:monobenzone; C045651:epigallocatechin gallate
keywords: EGCG; EGCG (PubChem CID: 65064); Monobenzone; Monobenzone (PubChem CID: 7638); Vitiligo